Invesco’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172M Sell
329,519
-35,795
-10% -$17.1M 0.03% 711
2025
Q4
$213M Buy
365,314
+65,749
+22% +$33.6M 0.03% 655
2025
Q3
$137M Buy
299,565
+99,209
+50% +$37M 0.02% 762
2025
Q2
$60.6M Buy
200,356
+67,422
+51% +$20.1M 0.01% 986
2025
Q1
$44M Buy
132,934
+3,860
+3% +$1.27M 0.01% 1088
2024
Q4
$39.8M Buy
129,074
+8,828
+7% +$2.48M 0.01% 1149
2024
Q3
$25.5M Sell
120,246
-13,512
-10% -$3.46M ﹤0.01% 1352
2024
Q2
$37.5M Buy
133,758
+53,566
+67% +$12.8M 0.01% 1134
2024
Q1
$21.4M Buy
80,192
+71,530
+826% +$16.9M ﹤0.01% 1410
2023
Q4
$2M Buy
8,662
+1,557
+22% +$272K ﹤0.01% 2611
2023
Q3
$1.04M Sell
7,105
-15,612
-69% -$2.94M ﹤0.01% 2844
2023
Q2
$5.25M Buy
22,717
+623
+3% +$169K ﹤0.01% 2217
2023
Q1
$5.35M Sell
22,094
-10,890
-33% -$2.97M ﹤0.01% 2186
2022
Q4
$9.57M Buy
32,984
+27,014
+452% +$2.64M ﹤0.01% 1877
2022
Q3
$388K Buy
5,970
+635
+12% +$44.1K ﹤0.01% 3382
2022
Q2
$382K Buy
5,335
+61
+1% +$4.48K ﹤0.01% 3471
2022
Q1
$518K Sell
5,274
-1,806
-26% -$152K ﹤0.01% 3370
2021
Q4
$600K Sell
7,080
-570
-7% -$46.8K ﹤0.01% 3311
2021
Q3
$610K Buy
7,650
+882
+13% +$76.2K ﹤0.01% 3338
2021
Q2
$659K Buy
6,768
+2,268
+50% +$268K ﹤0.01% 3296
2021
Q1
$527K Buy
4,500
+422
+10% +$49.2K ﹤0.01% 3321
2020
Q4
$454K Buy
4,078
+1,047
+35% +$128K ﹤0.01% 3242
2020
Q3
$360K Sell
3,031
-52
-2% -$5.65K ﹤0.01% 3251
2020
Q2
$349K Sell
3,083
-179
-5% -$17.6K ﹤0.01% 3283
2020
Q1
$217K Buy
+3,262
New +$272K ﹤0.01% 3371
2019
Q3
Sell
-66,896
Closed -$7.01M 3707
2019
Q2
$7.01M Buy
66,896
+41,083
+159% +$4.4M ﹤0.01% 1979
2019
Q1
$3.23M Buy
+25,813
New +$3.21M ﹤0.01% 2299
2018
Q3
Sell
-2,182
Closed -$610K 3906
2018
Q2
$610K Sell
2,182
-120,430
-98% -$21.1M ﹤0.01% 3341
2018
Q1
$14.3M Buy
+122,612
New +$15.1M 0.01% 1346
2015
Q3
Sell
-61
Closed -$5K 3909
2015
Q2
$5K Buy
+61
New +$5.12K ﹤0.01% 4207

Other funds holding MDGL